On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...

There are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...

For the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...

Has a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

If you buy small-cap stocks today, are you taking a risk or managing it? To some it might appear you are taking a risk, but there is a high...

In the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...

Twelve Indian companies announced over USD 1.1 billion in US investments across aerospace, defense, energy, and AI sectors at the SelectUSA...

Exports from Indore's Special Economic Zone have surged by 32 percent. This significant growth reached Rs 8,127.67 crore in the first seven...

The fresh funds will be used for brand building, expanding the customer base, product development, and offline expansion. The Indore, Madhy...

Candytoy Corporate, the maker of candy toys for major brands, planned to hit a Rs 450 crore turnover by the next fiscal. To achieve this, t...

A press release from the city-based drug maker said Lighthouses are factories leading the way in Fourth Industrial Revolution (Industry 4.0...

On Lupin's Pithampur (Indore) plant, the US health regulator said the company invalidated initial OOS laboratory results without adequate i...

The proposed fertiliser plant will be made ready for manufacturing within three years, he said.

Glenmark has a significant presence in branded generics markets. It's subsidiary Glenmark Generics has robust presence in the US business.

With the approval, this plant is now the third plant of Torrent Pharma to receive USFDA approval, out of its 5 manufacturing plants.

According to reports, USFDA had sent letter to the company after its officials conducted inspection of the Indore plant between July and Au...